Suicide Prevention Strategies

Registration Options

Activity Dates: 04/27/2020 - 04/27/2023

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Suicide is the 10th leading cause of death in the United States resulting in more than 47,000 deaths in 2017, or about one death every 11 minutes. Suicide rates vary by race/ethnicity, age, and other population characteristics, and there are more than 120 prescription drugs with labeling that includes language about suicidal ideation or behavior. There is a great need for widespread education about suicide awareness and prevention and for health care entities to adopt a collaborative approach to the problem. For psychiatric pharmacists, being able to identify patients with suicidal ideation and respond to this risk is a key skill set that must developed through didactic education and clinical experience. In this session, participants will learn about standardized, evidence-based suicide screening and structured methods for the subsequent evaluation of those who screen positive for suicide risk.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

Sign in (or create a FREE account).
Register for this course.
Review the full content of the activity and reflect upon its teachings.
Complete the post-test at the end of the activity no later than the closing activity date.
Complete the evaluation at the end of the activity.
If necessary, complete the post-test retest no later than the closing activity date.
Receive a passing grade (70%).
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

View System Requirements to Access All Session Resources

AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:

A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended, or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat or FoxIt
An adequate device and Internet connection: Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent); Memory: 4 GB; Storage: 5 GB available; Internet speed: 4.0 Mbps (up/down)

AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.

Faculty Information

Lisa K. Kearney, PhD, ABPP
Tera Moore, PharmD, BCACP

View biographical information

Lisa K. Kearney, PhD, ABPP
Acting Deputry Director-Suicide Prevention
Office of Mental Health and Suicide Prevention, VA Central Office
San Antonio, TX

Dr. Lisa K. Kearney is the Acting Deputy Director, Suicide Prevention for the U.S. Department of Veterans Affairs. Her work focuses on the development of VA’s comprehensive public health approach to suicide prevention and overseeing the office’s day-to-day operations.

Dr. Kearney recently served as the Associate Director of Education at the VA Center for Integrated Healthcare. Dr. Kearney previously worked nationally as part of the executive team in the VA Office of Mental Health Operations as the Senior Consultant for Technical Assistance, overseeing mental health policy implementation through quality improvement site visits across the VA system. At the local level, Dr. Kearney served as the Chief of Psychology, Assistant Chief, Director of Training, and Director of Primary Care- Mental Health Integration at the South Texas Veterans Health Care System.

Dr. Kearney is also a Clinical Associate Professor of Psychiatry at the University of Texas Health San Antonio. She is an Associate Editor for Psychological Services and the Journal of Health Service Psychology and an Editor for Psychology of Men and Masculinity. She currently serves as the President of the American Academy of Clinical Health Psychology. She is a graduate of the University of Texas at Austin with a PhD in Counseling Psychology and is board certified in Clinical Health Psychology.

Tera Moore, PharmD, BCACP
National PBM Program Manager, Clinical Practice Integration and Model Advancement Pharmacy Benefits Management, Clinical Pharmacy Practice Office
VA Central Office
Aurora, CO

Tera Moore, Pharm.D., BCPS, BCACP is the National Program Manager for Clinical Practice Integration and Model Advancement with the Department of Veterans Affairs (VA) Pharmacy Benefits Management Service, Clinical Pharmacy Practice Office (CPPO). Dr. Moore received her Pharm.D. degree from the University of New Mexico and completed an ASHP-accredited Ambulatory Care Specialty residency at the South Texas Veterans Health Care System (STVHCS) in San Antonio, TX. She has over sixteen years in primary care clinical practice, residency program director and leadership roles including Associate Chief for Clinical Pharmacy Services. Dr. Moore was a past recipient of the Certificate of Commitment from the VHA Acting Deputy Undersecretary for Patient Care Services and the VHA Under Secretary for Health Pharmacy Benefits Management Innovation Award. As the National Program Manager, Dr. Moore develops and manages initiatives that aid in demonstrating the value and criticality of advancing clinical pharmacy practice across VA facilities. She has a particular emphasis on program development, implementation and outcomes/impact assessments designed to evaluate the impact of clinical pharmacy services on costs and quality of patient care in Mental Health and Substance Use Disorders. She was a member of the National Quality Forum’s National Quality Partners™ Serious Mental Illness Action Team in 2019 and has given multiple presentations related to clinical pharmacy practice. She is an active member of the American Society of Health System Pharmacists (ASHP) and the College of Psychiatric and Neurologic Pharmacists.

Learning Objectives

Apply the public health approach for suicide prevention and to effectively change the culture to promote suicide prevention.
Evaluate the evidence of the role of the pharmacist and the impact on suicide prevention.
Outline the steps needed for implementation of pharmacist provider-based suicide risk evaluation and prevention strategies across practice settings.

Continuing Education Credit and Disclosures

Activity Dates: 04/27/2020 - 04/27/2023
ACPE Contact Hours: 1
ACPE Number: 0284-0000-20-041-H04-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPE The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

View planning committee disclosures

2020 CPNP Recertification Editorial Board Disclosures

Mary C. Borovicka, PharmD, BCPP, BCPS
Associate Professor
University of Toledo College of Pharmacy and Pharmaceutical Sciences
Cleveland, OH
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Ohio Pharmacists Association - LAI and naltrexone training inj

Beth DeJongh, PharmD, BCPP, BCPS
Recertification Editorial Board Vice Chair
Pharmacist
Concordia University Wisconsin
Mequon, WI
No Relevant Financial Relationships to Disclose

Sara E. Dugan, PharmD, BCPP, BCPS
Associate Professor
Northeast Ohio Medical University College of Pharmacy and Medicine
Rootstown, OH
Educational Grants, Research Grants or Contracts: Ohio Colleges of Medicine Government Research Center,
Northeast Ohio Medical University College of Medicine Department of Psychiatry

Clayton D. English, PharmD, BCPS, BCPP, BCGP
Associate Professor
Albany College of Pharmacy and Health Sciences
Colchester, VT
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Univeristy of Florida-Medication Therapy Management-Lecturer
Non-Financial Interests: Drug Utilization Review Board-Vermont State Medicaid, Board Member

Michelle L. Geier, PharmD, BCPP
Psychiatric Clinical Pharmacist Supervisor
San Francisco Department of Public Health
San Francisco, CA
No Relevant Financial Relationships to Disclose

Rebecca Graham, PharmD, BCPP
Clinical Pharmacy Specialist - Mental Health
Corporal Michael J. Crescenz VA Medical Center in Philadelphia
Philadelphia, PA
No Relevant Financial Relationships to Disclose

Courtney A. Iuppa, PharmD, BCPP
Clinical Pharmacy Manager & Residency Program Director
Center for Behavioral Medicine
Kansas City, MO
No Relevant Financial Relationships to Disclose

Rex S. Lott, PharmD, BCPP
BCPP Program Director
Professor Emeritus of Pharmacy Practice
Idaho State University - College of Pharmacy
Meridian, ID
No Relevant Financial Relationships to Disclose

Monica Mathys, PharmD, BCPP, BCGP
Associate Professor
Texas Tech University School of Pharmacy
Dallas, TX
Non-Financial Interests: CPNP Foundation Board member

Sarah T. Melton, PharmD, BCPP, BCACP, FASCP
Recertification Editorial Board Chair
Professor of Pharmacy Practice
Gatton College of Pharmacy
Johnson City, TN
Non-Financial Interests: One Care of Southwest Virginia

Thea R. Moore, PharmD, BCPP
Associate Professor
University of South Florida
Tampa, FL
Educational Grants, Research Grants or Contracts: Agency for Health Care Administration

Jessica L. Mulhollan, PharmD, BCPP
Psychiatric Clinical Pharmacy Specialist
Cleveland Clinic Marymount Hospital
Garfield Heights, OH
No Relevant Financial Relationships to Disclose

Sandra Mullen, PharmD, BCPP
Clinical Pharmacy Specialist - Psychiatry
VCU Health Systems
Richmond, VA
Non-Financial Interests: Lambda Kappa Sigma Grand Council (Executive Board)

Stephanie Nichols, PharmD, BCPP, BCPS, FCCP
Associate Professor of Pharmacy Practice
Husson University
Saco, ME
Non-Financial Interests: Member of the New England Comparative Effectiveness Public Advisory Committee of the Institute for Clinical and Economic Review,
Maine Independent Clinical Information Service Academic Detailing Advisory Committee

Sarah J. Popish, PharmD, BCPP
Academic Educator
Department of Veterans Affairs
Vallejo, CA
No Relevant Financial Relationships to Disclose

Megan M. Sarashinsky, PharmD, BCPP
Clinical Pharmacy Specialist
CJW Medical Center
Richmond, VA
No Relevant Financial Relationships to Disclose

Andrea Winterswyk, PharmD, BCPS, BCPP
Mental Health Clinical Pharmacy Specialist
Boise Veterans Affairs Medical Center
Boise, ID
No Relevant Financial Relationships to Disclose

Kara R. Wong, PharmD, BCPP
Clinical Pharmacy Specialist, Mental Health; PGY2 Psychiatric Pharmacy Residency Program Director
Minneapolis VA Health Care System
Minneapolis, MN
No Relevant Financial Relationships to Disclose

All relevant relationships have been mitigated.

View disclaimer and disclosure of off-label use

Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

View fair balance and integrity statement

It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.